Abeona Therapeutics Inc. - Special Call Transcript
At this time, I would like to welcome everyone to the Abeona Therapeutics WORLDSymposium Data Review Investor Webinar. As a reminder, today's conference is being recorded, and a replay will be made available on the Abeona website following the event. (Operator Instructions)
I'll now turn the call over to Greg Gin, Vice President of Investor Relations and Corporate Communications at Abeona. You may begin your conference.
Thank you, Sarah. Good afternoon, and thank you for joining us as we review the new positive data from 2 ongoing Phase I/II clinical trials of Abeona's AAV-based gene therapies, ABO-102 and ABO-101 being studied in MPS IIIA and MPS IIIB, respectively. These data were highlighted in late-breaking platform oral presentations at the Virtual 17th Annual WORLDSymposium on February 12. The presentation slides are available on Abeona's website at www.abeonatherapeutics.com and an archive of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
